Top U.S. SNRIs based on revenue 2013
This statistic displays the top nine serotonin-norepinephrine reuptake inhibitors (SNRIs) based on total U.S. revenue in 2013. In that year, Pristiq was among the leading SNRIs generating 570 million U.S. dollars in revenue in the United States. SNRIs are a type of antidepressant drug used to treat major depression disorder or other mood disorders. They can also be used for anxiety disorders, obsessive-compulsive disorder, and other related disorders.
